Lv1
48 积分 2026-07-15 加入
Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trial
2天前
已完结
Boosting anti-leukemia cytotoxicity of CD4 and cD8 T cellsthrough combined inhibition of MEK and HDAC
7天前
已关闭
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active
7天前
已完结
Receptor-interacting Protein Kinase 2 Is an Immunotherapy Target in Pancreatic Cancer
20天前
已完结
告别专业主义
1个月前
已关闭
皖公网安备34019202002308
